Live from the NIH registry
Studies recruiting near Athens right now
Top 25 of 75 recruiting studies, sorted by proximity — each links to its official registry page
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
University Cancer and Blood Center — Athens, Georgia (0.9 mi)
· Sponsor: Revolution Medicines, Inc.
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Athens, Georgia (0.9 mi)
· Sponsor: 89bio, Inc.
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Pulmonary Hypertension Associated With HFpEF
Phase 3
Interventional 540 participants sought
Tenax Investigational Site — Athens, Georgia (0.9 mi)
· Sponsor: Tenax Therapeutics, Inc.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Athens, Georgia (0.9 mi)
· Sponsor: AstraZeneca
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Pfizer
Steps Towards Osteoarthritis Prevention
Anterior Cruciate Ligament Injuries
N/A
Interventional 56 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
Stomatitis
Phase 4
Interventional 100 participants sought
Research Site — Athens, Georgia (0.9 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Diffuse Large B-Cell Lymphoma
Phase 3
Interventional 1,046 participants sought
University Cancer & Blood Center, LLC ( Site 0141) — Athens, Georgia (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Athens, Georgia (0.9 mi)
· Sponsor: 89bio, Inc.
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF), Persistant Atrial Fibrillation
N/A
Interventional 699 participants sought
Piedmont Athens Regional — Athens, Georgia (0.9 mi)
· Sponsor: Boston Scientific Corporation
Intermittent Cottonseed Oil Consumption
Dyslipidemia, Overweight and Obesity
N/A
Interventional 75 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
University Cancer And Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Relapsed or Refractory Multiple Myeloma
Phase 3
Interventional 810 participants sought
Local Institution - 0211 — Athens, Georgia (0.9 mi)
· Sponsor: Celgene
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
N/A
Observational 2,450 participants sought
Pulmonary & Sleep Specialists of Northeast Georgia, P.C — Winder, Georgia (20.3 mi)
· Sponsor: Harbinger Health
Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures
Blood Loss, Surgical
N/A
Interventional 40 participants sought
University Surgical Vascular — Watkinsville, Georgia (6.5 mi)
· Sponsor: University Surgical Vascular
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: NRG Oncology
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2, Phase 3
Interventional 982 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Pfizer
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prostate Cancer
Phase 4
Interventional 700 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
University Cancer and Blood Center Athens Comprehensive Cancer Center — Athens, Georgia (0.9 mi)
· Sponsor: BeOne Medicines
Mom Multi Postnatal Supplementation Trial
Postnatal Care
N/A
Interventional 80 participants sought
UGA Clinical & Translational Unit — Athens, Georgia (0.9 mi)
· Sponsor: Perelel Inc.
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 744 participants sought
Research Site — Athens, Georgia (0.9 mi)
· Sponsor: AstraZeneca
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
Endometriosis, Endometrioma
N/A
Observational 140 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: Johns Hopkins University
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Early Breast Cancer
Phase 3
Interventional 1,400 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Non-small Cell Lung Cancer
Phase 2
Interventional 66 participants sought
University Cancer & Blood Center (UCBC) - Athens — Athens, Georgia (0.9 mi)
· Sponsor: Teligene US
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 120 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Pfizer